Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,996,000 | 2,730,000 | 8,127,000 | 7,856,000 | 5,572,000 |
| Depreciation Amortization | 2,014,000 | 1,008,000 | 5,090,000 | 3,912,000 | 2,716,000 |
| Income taxes - deferred | 731,000 | 237,000 | -1,331,000 | 580,000 | 439,000 |
| Accounts receivable | N/A | N/A | 195,000 | N/A | N/A |
| Other Working Capital | -247,000 | -899,000 | 4,908,000 | -1,544,000 | -1,631,000 |
| Other Operating Activity | 167,000 | 71,000 | 1,249,000 | 1,461,000 | 1,217,000 |
| Operating Cash Flow | $7,661,000 | $3,147,000 | $18,238,000 | $12,265,000 | $8,313,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,649,000 | -11,013,000 | 716,000 | -1,727,000 | -3,643,000 |
| PPE Investments | -522,000 | -253,000 | -1,701,000 | -1,312,000 | -868,000 |
| Net Acquisitions | N/A | N/A | -1,184,000 | -962,000 | -962,000 |
| Purchase Of Investment | -5,266,000 | -3,442,000 | -9,357,000 | -5,292,000 | -3,856,000 |
| Sale Of Investment | 3,484,000 | 889,000 | 1,009,000 | 639,000 | 632,000 |
| Other Investing Activity | 346,000 | 185,000 | -2,318,000 | -1,401,000 | -251,000 |
| Investing Cash Flow | $-26,607,000 | $-13,634,000 | $-12,835,000 | $-10,055,000 | $-8,948,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 21,754,000 | 10,774,000 | 40,119,000 | 31,035,000 | 16,310,000 |
| Debt Issued | 23,996,000 | 13,392,000 | 605,000 | 605,000 | 602,000 |
| Debt Repayment | -908,000 | -303,000 | -1,053,000 | -561,000 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 41,000 | 33,000 |
| Common Stock Repurchased | N/A | N/A | -500,000 | -500,000 | -500,000 |
| Dividend Paid | -3,200,000 | -2,133,000 | -8,541,000 | -6,409,000 | -4,277,000 |
| Other Financing Activity | -22,599,000 | -12,095,000 | -37,190,000 | -28,518,000 | -14,097,000 |
| Financing Cash Flow | $19,043,000 | $9,635,000 | $-6,560,000 | $-4,307,000 | $-1,929,000 |
| Exchange Rate Effect | 25,000 | -23,000 | -127,000 | -44,000 | -22,000 |
| Beginning Cash Position | 2,122,000 | 2,122,000 | 3,406,000 | 3,406,000 | 3,406,000 |
| End Cash Position | 2,244,000 | 1,247,000 | 2,122,000 | 1,265,000 | 820,000 |
| Net Cash Flow | $122,000 | $-875,000 | $-1,284,000 | $-2,141,000 | $-2,586,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,661,000 | 3,147,000 | 18,238,000 | 12,265,000 | 8,313,000 |
| Capital Expenditure | -522,000 | -253,000 | -1,701,000 | -1,312,000 | -868,000 |
| Free Cash Flow | 7,139,000 | 2,894,000 | 16,537,000 | 10,953,000 | 7,445,000 |